Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 65 announcements

Share price: ₹832.30
Market cap: ₹16,360 Cr
Revenue (annual): ₹7,345 Cr
Net profit (annual): ₹674.8 Cr
P/E (TTM): 23.6×Sector 47.4×
Promoter holding: 69.87%+0.13% QoQ
FII holding: 4.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 13 Debt & Borrowing 9 Merger & Restructuring 8 Regulatory Approval 7 Earnings Call 5 Business Update 5 Financial Results 3 Results Update 2 Other Announcement 2 Credit Rating 2 Board Meeting Date 2 Annual General Meeting 2 Legal & Regulatory 1 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

1 Jul 2026 18:43 IST BSE

Credit Rating

Alembic Pharmaceuticals Credit Rating

CRISIL has reaffirmed ratings for Alembic Pharmaceuticals. The ratings cover bank loans and commercial papers totaling ₹2,200 Crore.

Value: ₹2,200 Cr

Read the filing ↗

11 Jun 2026 22:02 IST BSE

Credit Rating

Alembic Pharmaceuticals Credit Rating

CARE Ratings reaffirmed Alembic Pharmaceuticals' Commercial Paper rating at CARE A1+. The reaffirmation reflects stable credit quality and no change in outlook.

Read the filing ↗